Table: Jcr Pharmaceuticals -Q1 group results

JCR Pharmaceuticals

26/07/2023 08:00

Jul 26 (Reuters)- 
             Jcr Pharmaceuticals Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               10.81               9.61             36.90    
                   (+12.5 pct)         (-2.1 pct)       (+7.4 pct)  
  Operating            2.07               1.54              5.60    
                   (+34.5 pct)         (-48.5 pct)      (+12.5 pct) 
  Recurring            2.26               2.08              5.20    
                   (+8.5 pct)          (-30.5 pct)      (-4.0 pct)  
  Net                  1.61               1.37              3.80    
                   (+17.7 pct)         (-10.7 pct)      (+0.7 pct)  
  EPS               12.91 yen           11.06 yen        30.56 yen  
  EPS Diluted       12.85 yen           11.02 yen                   
  Ann Div                               20.00 yen        20.00 yen  
  -Q2 div                               10.00 yen        10.00 yen  
  -Q4 div                               10.00 yen        10.00 yen  
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T